Search Within

Genitourinary Oncology Service

  1. "Jaclyn Hechtman"
Formats
  1. Journal Article (30)
  2. Meeting Abstract (25)
Groups
  1. Department of Medicine (55)
  2. GSK Faculty (55)
  3. Solid Tumor Oncology Division (55)
  4. Human Oncology and Pathogenesis Program (53)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (52)
  6. Department of Pathology and Laboratory Medicine (48)

More Groups

People
  1. Jaclyn Hechtman (55)
  2. David Solit (52)
  3. Michael Berger (40)
  4. Nikolaus Schultz (35)
  5. Yelena Janjigian (25)
  6. Geoffrey Ku (20)

More People

Years
  1. 2025 (1)
  2. 2023 (1)
  3. 2022 (1)
  4. 2021 (5)
  5. 2020 (5)
  6. 2019 (15)

More Years

Publications
  1. Journal of Clinical Oncology (21)
  2. Clinical Cancer Research (8)
  3. Annals of Oncology (3)
  4. JCO Precision Oncology (3)
  5. Cancer Discovery (2)
  6. Cancer Research (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (24)
  2. American Association for Cancer Research (13)
  3. Oxford University Press (5)
  4. Nature Publishing Group (3)
  5. American Medical Association (2)
  6. Springer (2)

More Publishers

Results (55)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Sarcoid-like reactions in patients treated with checkpoint inhibitors for advanced solid tumors
    Journal Article

    Nykaza, I.; Murciano-Goroff, Y. R.; Desilets, A.; Harada, G.; Postow, M. A.; Callahan, M. K.; Lee, C. H.; Rudin, C. M.; Kelsen, D. P.; Stadler, Z. K.; more...
    The Oncologist (2025)

    Fulltext@MSK | Save
  • Determinants of survival with combined HER2 and PD-1 blockade in metastatic esophagogastric cancer
    Journal Article

    Maron, S. B.; Chatila, W.; Walch, H.; Chou, J. F.; Ceglia, N.; Ptashkin, R.; Do, R. K. G.; Paroder, V.; Pandit-Taskar, N.; Lewis, J. S.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Defining and targeting esophagogastric cancer genomic subsets with patient-derived xenografts
    Journal Article

    Moy, R. H.; Walch, H. S.; Mattar, M.; Chatila, W. K.; Molena, D.; Strong, V. E.; Tang, L. H.; Maron, S. B.; Coit, D. G.; Jones, D. R.; more...
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • Early predictors of benefit to dual anti-PD1/HER2 inhibition: Biomarker analysis from phase 2 trial of pembrolizumab/trastuzumab in HER2-positive metastatic esophagogastric (mEG) cancer
    Meeting Abstract

    Maron, S. B.; Chatila, W. K.; Walch, H. S.; Ptashkin, R.; Sabwa, S.; Ling, L.; Nagy, R.; Simmons, M.; Do, R. K. G.; Paroder, V.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Genetic determinants of outcome in intrahepatic cholangiocarcinoma
    Journal Article

    Boerner, T.; Drill, E.; Pak, L. M.; Nguyen, B.; Sigel, C. S.; Doussot, A.; Shin, P.; Goldman, D. A.; Gonen, M.; Allen, P. J.; more...
    Hepatology (2021)

    Fulltext@MSK | Save
  • Prevalence of germline alterations on targeted tumor-normal sequencing of esophagogastric cancer
    Journal Article

    Ku, G. Y.; Kemel, Y.; Maron, S. B.; Chou, J. F.; Ravichandran, V.; Shameer, Z.; Maio, A.; Won, E. S.; Kelsen, D. P.; Ilson, D. H.; more...
    JAMA Network Open (2021)

    Fulltext@MSK | Save
  • Enhanced specificity of clinical high-sensitivity tumor mutation profiling in cell-free DNA via paired normal sequencing using MSK-ACCESS
    Journal Article

    Brannon, A. R.; Jayakumaran, G.; Diosdado, M.; Patel, J.; Razumova, A.; Hu, Y.; Meng, F.; Haque, M.; Sadowska, J.; Murphy, B. J.; more...
    Nature Communications (2021)

    Fulltext@MSK | Save
  • Next-generation sequencing of 487 esophageal adenocarcinomas reveals independently prognostic genomic driver alterations and pathways
    Journal Article

    Sihag, S.; Nussenzweig, S. C.; Walch, H. S.; Hsu, M.; Tan, K. S.; Sanchez-Vega, F.; Chatila, W. K.; De La Torre, S. A.; Patel, A.; Janjigian, Y. Y.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Pembrolizumab with trastuzumab and chemotherapy (PTC) in HER2-positive metastatic esophagogastric cancer (mEG): Plasma and tumor-based biomarker analysis
    Meeting Abstract

    Maron, S. B.; Chatila, W. K.; Millang, B. M.; Sabwa, S.; Chou, J. F.; Ling, L.; Nagy, R.; Simmons, M.; Do, R. K. G.; Paroder, V.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Prevalence and clinical characterization of MMR-D/MSI extra-colonic cancers among germline PMS2 mutation carriers
    Meeting Abstract

    Latham, A.; Salo-Mullen, E. E.; Catchings, A.; Ranganathan, M.; Fiala, E.; Kemel, Y.; Konner, J. A.; Soslow, R. A.; Momeni-Boroujeni, A.; Shia, J.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save